OncBioMune Pharmaceuticals, Inc Uncategorized Contracts & Agreements

31 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Offer Letter between the Company and Faith Zaslavsky, dated December 5, 2022
OncBioMune Pharmaceuticals, Inc
Biotechnology
CO
2022
Form of 10% Original Issue Discount Senior Secured Convertible Debentures (Exchanged Debentures)
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2022
Form of 10% Original Issue Discount Senior Secured Convertible Debentures
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2022
Engagement Letter, by and between Carter, Terry & Company and Theralink Technologies, Inc., dated December 15, 2021, as amended
OncBioMune Pharmaceuticals, Inc
Biotechnology
2022
Warrants Agreement between Cavalry I LP and OncBioMune, Inc, dated November 13, 2018
OncBioMune Pharmaceuticals, Inc
Biotechnology
2018
Form of Warrants issued September 24, 2018
OncBioMune Pharmaceuticals, Inc
Biotechnology
2018
ForbearanceAgreement
OncBioMune Pharmaceuticals, Inc
Biotechnology
2017
NON-QUALIFIEDSTOCK OPTION AGREEMENT FOR DIRECTORS
OncBioMune Pharmaceuticals, Inc
Biotechnology
2017
FORMOF NON-QUALIFIEDSTOCK OPTION AGREEMENT
OncBioMune Pharmaceuticals, Inc
Biotechnology
2017
FORMOF
OncBioMune Pharmaceuticals, Inc
Biotechnology
2017
STOCKHOLDERS’AGREEMENT datedas of March10, 2017 among ONCBIOMUNEPHARMACEUTICALS, INC. and THESTOCKHOLDERS PARTY HERETO
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2017
Representations
OncBioMune Pharmaceuticals, Inc
Biotechnology
2017
PARTIES
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2017
AMENDEDAND RESTATED SECURITIESPURCHASE AGREEMENT
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2016
SECURITIESPURCHASE AGREEMENT
OncBioMune Pharmaceuticals, Inc
Biotechnology
NY
2016
Account
OncBioMune Pharmaceuticals, Inc
Biotechnology
AL
2016
SABRCapital Management LLC 335 Madison Avenue, Suite 1100, New York, New York 10017
OncBioMune Pharmaceuticals, Inc
Biotechnology
2016
EMPLOYMENTAGREEMENT
OncBioMune Pharmaceuticals, Inc
Biotechnology
LA
2016
PURCHASEAGREEMENT
OncBioMune Pharmaceuticals, Inc
Biotechnology
IL
2015
PURCHASEAGREEMENT
OncBioMune Pharmaceuticals, Inc
Biotechnology
IL
2015
DEBTSETTLEMENT AGREEMENT
OncBioMune Pharmaceuticals, Inc
Biotechnology
FL
2015
SHAREEXCHANGE AGREEMENT Dated June22, 2015 byand among QUINTMEDIA, INC., a Nevada Corporation asthe Acquiror and Parent. and ONCBIOMUNE,INC., aLouisiana corporation and...
OncBioMune Pharmaceuticals, Inc
Biotechnology
LA
2015
DEBTSETTLEMENT AGREEMENT
OncBioMune Pharmaceuticals, Inc
Biotechnology
FL
2015
Co-Promotion Agreement dated February 21, 2012 with Apricus Biosciences, Inc. (portions of the exhibit have been omitted pursuant to a request for confidential treatment)
OncBioMune Pharmaceuticals, Inc
Biotechnology
CA
2012
Form of independent contractor agreement
OncBioMune Pharmaceuticals, Inc
Biotechnology
NJ
2011
Co-promotion agreement with Bi-Coastal Pharmaceuticals effective September 12, 2011 (portions of the exhibit have been omitted pursuant to a request for confidential treatment)
OncBioMune Pharmaceuticals, Inc
Biotechnology
2011
Cancellation Agreement dated February 9, 2011 with David Tousley
OncBioMune Pharmaceuticals, Inc
Biotechnology
NJ
2011
Cancellation Agreement dated February 9, 2011 with Cameron Durrant
OncBioMune Pharmaceuticals, Inc
Biotechnology
NJ
2011
Lock-up Agreement dated February 9, 2011 with David Tousley
OncBioMune Pharmaceuticals, Inc
Biotechnology
NJ
2011
Lock-up Agreement dated February 9, 2011 with Cameron Durrant
OncBioMune Pharmaceuticals, Inc
Biotechnology
NJ
2011
Letter of Intent with Granisol Oral Solution
OncBioMune Pharmaceuticals, Inc
Biotechnology
NJ
2010